Rare Dedication

Welcome to Leadiant Biosciences, Inc.

The product information provided in this website is intended only for residents of the United States.

About Leadiant Biosciences

We’re rare. Leadiant Biosciences is a research-based pharmaceutical company that dedicates considerable scientific and financial resources to the research, development, and distribution of novel and effective therapies for patients affected by rare disease. At Leadiant Biosciences, our legacy of serving patients is as strong as the future we envision.

Learn More
Nancy Parsons
Congratulations, Nancy!

Your induction into the Medical Marketing and Media’s Hall of Femme is well-deserved.

You make a tremendously positive impact on Leadiant and the lives of people living with ultra-rare diseases. Through your leadership and actions, you contribute to a patient-centered culture that drives business performance.

Latest News

Leadiant Shows Rare Dedication to Patients With Recent FDA Approval of Revcovi

| Uncategorized | No Comments
Leadiant Biosciences, Inc. formerly known as Sigma-Tau Pharmaceuticals, recently received FDA approval for Revcovi®, which provides improved treatment for patients living with ADA-SCID, better known as "Bubble Boy Disease." The…

Patient Stories

We are passionate about putting the patient first and ensuring their voice, experience and insights are represented in everything we do. Hear from our patients about their journeys living with a rare disease.

Drug Development Process

Discovering and developing a new drug is an expensive and challenging process that can take between 10 and 15 years from discovery to commercialization.

Patients & Caregivers

At Leadiant Biosciences, we understand that people living with rare diseases have needs that extend far beyond medicine, which is why we provide resources and educational materials to support patients and their families throughout their journeys.

Learn More

Research and Development

We are driven to provide excellence and innovation because we understand in many cases, patients have no other treatment options.

Our innovative research programs and development of novel product candidates are led by scientists in partnership with a wide range of physicians, researchers, and leading academic biotechnology organizations around the world.

Learn More

Role of Patients in Research and Drug Development

Patients and caregivers play an increasingly important role in researching and developing new therapies for rare and ultra-rare diseases. We are passionate about putting the patient first and ensuring their voice, experience and insights are heard. This can include funding research through donations, participating in a clinical trial, contributing to a patient registry, working with regulatory decision makers, and sharing experiences to help companies and researchers better understand a disease.

Learn More

Culture and Career

Leadiant Biosciences is a research-based pharmaceutical company unlike any other. We are united by rare dedication and a unique culture where every employee contributes, and every patient matters.

Learn More